NEW YORK CITY, NY / ACCESS Newswire / November 10, 2026 / On November 5, 2026, approximately $130 million in expected revenue was removed from the 2026 outlook of Axon Enterprise, Inc. (NASDAQ: AXON). The Company disclosed that three Federal Dedrone counter-drone deployments had been delayed and cut its full-year revenue guidance to between $3.61 billion and $3.63 billion, and AXON shares fell. If you lost money on AXON stock, you are encouraged to submit your AXON loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The delayed projects include a $30 million Federal Dedrone deployment originally expected in the third quarter. They also include two additional Federal projects, totaling approximately $100 million, previously expected in the fourth quarter. Combined, the approximately $130 million represents about 3.5% of the revenue the Company had anticipated for 2026. Guidance now calls for approximately 30% growth, down from a prior range of $3.67 billion to $3.725 billion, or 32% to 34% growth.

The investigation includes whether Axon may not have adequately disclosed the extent to which its 2026 outlook rested on the timing of a small number of large Federal deployments.

AXON shareholders who suffered losses after the guidance cut can request a free review of their AXON losses or call (212) 363-7500.

ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.

Frequently Asked Questions About the AXON Investigation

Q: Who is conducting the AXON investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased AXON securities. The firm is nationally recognized and has been ranked in the ISS Top 50 for seven consecutive years.

Q: Who is eligible to participate in the AXON investigation? A: Investors who purchased AXON stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Axon Enterprise, Inc. made materially false or misleading statements regarding its 2026 revenue outlook and the deployment timing of its Federal Dedrone counter-drone business. When the Company disclosed that approximately $130 million of revenue from three delayed Federal Dedrone deployments had been removed from its 2026 outlook, the stock price declined.

Q: What do AXON investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my AXON shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AXON and sold at a loss may still participate in the investigation.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

SOURCE: Levi & Korsinsky, LLP